Q1 2024 Inhibikase Therapeutics Inc Earnings Call Transcript

May 16, 2024 / 12:00PM GMT
Operator

Greetings, and welcome to Inhibikase Therapeutics' First Quarter 2024 financial results conference call. (Operator Instructions) As a reminder, this conference is being recorded and it is now my pleasure to introduce your host, Mr. Alexander Lobo, Stern Investor Relations. Thank you, Mr. Lobo, you may begin.

Alexander Lobo - Stern Investor Relations - IR

Good morning, and welcome to inhibitors Therapeutics First Quarter 2024 financial results conference call and audio webcast. With me today is Dr. Milton Werner, Chief Executive Officer, and Garth Lees-Rolfe, Chief Financial Officer. On May 15th, Inhibikase issued a press release announcing financial results for the first quarter ended March 31st, 2024. We encourage everyone to read yesterday's press release as well as in heavy cases, quarterly report on Form 10-Q, which has been filed with the SEC.

The company's press release and Form 10-Q are also available on Inhibikase website. In addition, this conference call is being webcast through the Investor Relations section of the company's website and will

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot